IMMUNE DESIGN CORP.·4

Nov 9, 4:15 PM ET

ter Meulen Jan Henrik 4

4 · IMMUNE DESIGN CORP. · Filed Nov 9, 2018

Insider Transaction Report

Form 4
Period: 2018-11-07
ter Meulen Jan Henrik
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2018-11-07+23,36262,396 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Immune Design Corp. common stock.
  • [F2]Restricted stock units shall vest in a single installment on November 7, 2019, subject to the Reporting Person's continuous service through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION